nodes	percent_of_prediction	percent_of_DWPC	metapath
Iobenguane—Haematoma—Everolimus—kidney cancer	0.0694	0.0694	CcSEcCtD
Iobenguane—Haematoma—Sorafenib—kidney cancer	0.0602	0.0602	CcSEcCtD
Iobenguane—Haematoma—Sunitinib—kidney cancer	0.0579	0.0579	CcSEcCtD
Iobenguane—Injection site haemorrhage—Doxorubicin—kidney cancer	0.0481	0.0481	CcSEcCtD
Iobenguane—Haematoma—Capecitabine—kidney cancer	0.0319	0.0319	CcSEcCtD
Iobenguane—Contusion—Paclitaxel—kidney cancer	0.028	0.028	CcSEcCtD
Iobenguane—Flushing—Pazopanib—kidney cancer	0.0257	0.0257	CcSEcCtD
Iobenguane—Contusion—Capecitabine—kidney cancer	0.023	0.023	CcSEcCtD
Iobenguane—Flushing—Everolimus—kidney cancer	0.0203	0.0203	CcSEcCtD
Iobenguane—Flushing—Sorafenib—kidney cancer	0.0176	0.0176	CcSEcCtD
Iobenguane—Flushing—Sunitinib—kidney cancer	0.017	0.017	CcSEcCtD
Iobenguane—Flushing—Dactinomycin—kidney cancer	0.0161	0.0161	CcSEcCtD
Iobenguane—Hypersensitivity—Temsirolimus—kidney cancer	0.0154	0.0154	CcSEcCtD
Iobenguane—Pruritus—Temsirolimus—kidney cancer	0.0148	0.0148	CcSEcCtD
Iobenguane—Pruritus—Pazopanib—kidney cancer	0.0139	0.0139	CcSEcCtD
Iobenguane—Dizziness—Temsirolimus—kidney cancer	0.0138	0.0138	CcSEcCtD
Iobenguane—Rash—Temsirolimus—kidney cancer	0.0132	0.0132	CcSEcCtD
Iobenguane—Dermatitis—Temsirolimus—kidney cancer	0.0132	0.0132	CcSEcCtD
Iobenguane—Headache—Temsirolimus—kidney cancer	0.0131	0.0131	CcSEcCtD
Iobenguane—Dizziness—Pazopanib—kidney cancer	0.013	0.013	CcSEcCtD
Iobenguane—Rash—Pazopanib—kidney cancer	0.0124	0.0124	CcSEcCtD
Iobenguane—Dermatitis—Pazopanib—kidney cancer	0.0124	0.0124	CcSEcCtD
Iobenguane—Headache—Pazopanib—kidney cancer	0.0123	0.0123	CcSEcCtD
Iobenguane—Hypersensitivity—Vinblastine—kidney cancer	0.0115	0.0115	CcSEcCtD
Iobenguane—Hypersensitivity—Everolimus—kidney cancer	0.0115	0.0115	CcSEcCtD
Iobenguane—Flushing—Paclitaxel—kidney cancer	0.0114	0.0114	CcSEcCtD
Iobenguane—Pruritus—Everolimus—kidney cancer	0.011	0.011	CcSEcCtD
Iobenguane—Pruritus—Erlotinib—kidney cancer	0.0106	0.0106	CcSEcCtD
Iobenguane—Dizziness—Vinblastine—kidney cancer	0.0103	0.0103	CcSEcCtD
Iobenguane—Dizziness—Everolimus—kidney cancer	0.0103	0.0103	CcSEcCtD
Iobenguane—Hypersensitivity—Sorafenib—kidney cancer	0.00995	0.00995	CcSEcCtD
Iobenguane—Dizziness—Erlotinib—kidney cancer	0.00993	0.00993	CcSEcCtD
Iobenguane—Rash—Everolimus—kidney cancer	0.00981	0.00981	CcSEcCtD
Iobenguane—Dermatitis—Everolimus—kidney cancer	0.0098	0.0098	CcSEcCtD
Iobenguane—Headache—Vinblastine—kidney cancer	0.00978	0.00978	CcSEcCtD
Iobenguane—Headache—Everolimus—kidney cancer	0.00975	0.00975	CcSEcCtD
Iobenguane—Hypersensitivity—Sunitinib—kidney cancer	0.00957	0.00957	CcSEcCtD
Iobenguane—Pruritus—Sorafenib—kidney cancer	0.00955	0.00955	CcSEcCtD
Iobenguane—Rash—Erlotinib—kidney cancer	0.00946	0.00946	CcSEcCtD
Iobenguane—Dermatitis—Erlotinib—kidney cancer	0.00946	0.00946	CcSEcCtD
Iobenguane—Headache—Erlotinib—kidney cancer	0.0094	0.0094	CcSEcCtD
Iobenguane—Flushing—Capecitabine—kidney cancer	0.00936	0.00936	CcSEcCtD
Iobenguane—Pruritus—Sunitinib—kidney cancer	0.00919	0.00919	CcSEcCtD
Iobenguane—Hypersensitivity—Dactinomycin—kidney cancer	0.00906	0.00906	CcSEcCtD
Iobenguane—Dizziness—Sorafenib—kidney cancer	0.00893	0.00893	CcSEcCtD
Iobenguane—Dizziness—Sunitinib—kidney cancer	0.00859	0.00859	CcSEcCtD
Iobenguane—Rash—Sorafenib—kidney cancer	0.00851	0.00851	CcSEcCtD
Iobenguane—Dermatitis—Sorafenib—kidney cancer	0.00851	0.00851	CcSEcCtD
Iobenguane—Headache—Sorafenib—kidney cancer	0.00846	0.00846	CcSEcCtD
Iobenguane—Rash—Sunitinib—kidney cancer	0.00819	0.00819	CcSEcCtD
Iobenguane—Dermatitis—Sunitinib—kidney cancer	0.00819	0.00819	CcSEcCtD
Iobenguane—Headache—Sunitinib—kidney cancer	0.00814	0.00814	CcSEcCtD
Iobenguane—Hypersensitivity—Vincristine—kidney cancer	0.0081	0.0081	CcSEcCtD
Iobenguane—Rash—Dactinomycin—kidney cancer	0.00776	0.00776	CcSEcCtD
Iobenguane—Pruritus—Gemcitabine—kidney cancer	0.00738	0.00738	CcSEcCtD
Iobenguane—Dizziness—Vincristine—kidney cancer	0.00727	0.00727	CcSEcCtD
Iobenguane—Rash—Vincristine—kidney cancer	0.00693	0.00693	CcSEcCtD
Iobenguane—Dermatitis—Vincristine—kidney cancer	0.00692	0.00692	CcSEcCtD
Iobenguane—Headache—Vincristine—kidney cancer	0.00689	0.00689	CcSEcCtD
Iobenguane—Rash—Gemcitabine—kidney cancer	0.00657	0.00657	CcSEcCtD
Iobenguane—Dermatitis—Gemcitabine—kidney cancer	0.00657	0.00657	CcSEcCtD
Iobenguane—Headache—Gemcitabine—kidney cancer	0.00653	0.00653	CcSEcCtD
Iobenguane—Hypersensitivity—Paclitaxel—kidney cancer	0.00643	0.00643	CcSEcCtD
Iobenguane—Pruritus—Paclitaxel—kidney cancer	0.00618	0.00618	CcSEcCtD
Iobenguane—Flushing—Doxorubicin—kidney cancer	0.00603	0.00603	CcSEcCtD
Iobenguane—Dizziness—Paclitaxel—kidney cancer	0.00577	0.00577	CcSEcCtD
Iobenguane—Rash—Paclitaxel—kidney cancer	0.0055	0.0055	CcSEcCtD
Iobenguane—Dermatitis—Paclitaxel—kidney cancer	0.0055	0.0055	CcSEcCtD
Iobenguane—Headache—Paclitaxel—kidney cancer	0.00547	0.00547	CcSEcCtD
Iobenguane—Hypersensitivity—Capecitabine—kidney cancer	0.00528	0.00528	CcSEcCtD
Iobenguane—Pruritus—Capecitabine—kidney cancer	0.00507	0.00507	CcSEcCtD
Iobenguane—Dizziness—Capecitabine—kidney cancer	0.00474	0.00474	CcSEcCtD
Iobenguane—Rash—Capecitabine—kidney cancer	0.00452	0.00452	CcSEcCtD
Iobenguane—Dermatitis—Capecitabine—kidney cancer	0.00451	0.00451	CcSEcCtD
Iobenguane—Headache—Capecitabine—kidney cancer	0.00449	0.00449	CcSEcCtD
Iobenguane—Hypersensitivity—Doxorubicin—kidney cancer	0.0034	0.0034	CcSEcCtD
Iobenguane—Pruritus—Doxorubicin—kidney cancer	0.00327	0.00327	CcSEcCtD
Iobenguane—Dizziness—Doxorubicin—kidney cancer	0.00305	0.00305	CcSEcCtD
Iobenguane—Rash—Doxorubicin—kidney cancer	0.00291	0.00291	CcSEcCtD
Iobenguane—Dermatitis—Doxorubicin—kidney cancer	0.00291	0.00291	CcSEcCtD
Iobenguane—Headache—Doxorubicin—kidney cancer	0.00289	0.00289	CcSEcCtD
